A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma

被引：12

作者：

Lee, Hun J. ^{[1
]}

Badillo, Maria ^{[1
]}

Romaguera, Jorge ^{[1
]}

Wang, Michael ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 184卷 / 03期

关键词：

mantle cell lymphoma; carfilzomib; proteasome inhibition; relapsed lymphoma; refractory lymphoma; PROTEASOME INHIBITOR CARFILZOMIB; DOSE-ESCALATION; BORTEZOMIB;

D O I：

10.1111/bjh.15107

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：460 / 462

页数：3

共 10 条

[1] Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma [J].

Awan, Farrukh T. ;

Flynn, Joseph M. ;

Jones, Jeffrey A. ;

Andritsos, Leslie A. ;

Maddocks, Kami J. ;

Sass, Ellen J. ;

Lucas, Margaret S. ;

Chase, Weihong ;

Waymer, Sharon ;

Ling, Yonghua ;

Jiang, Yao ;

Phelps, Mitch A. ;

Byrd, John C. ;

Lucas, David M. ;

Woyach, Jennifer A. .

LEUKEMIA & LYMPHOMA, 2015, 56 (10) :2834-2840

[2] Revised response criteria for malignant lymphoma [J].

Cheson, Bruce D. ;

Pfistner, Beate ;

Juweid, Malik E. ;

Gascoyne, Randy D. ;

Specht, Lena ;

Horning, Sandra J. ;

Coiffier, Bertrand ;

Fisher, Richard I. ;

Hagenbeek, Anton ;

Zucca, Emanuele ;

Rosen, Steven T. ;

Stroobants, Sigrid ;

Lister, T. Andrew ;

Hoppe, Richard T. ;

Dreyling, Martin ;

Tobinai, Kensei ;

Vose, Julie M. ;

Connors, Joseph M. ;

Federico, Massimo ;

Diehl, Volker .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586

[3] Phase II study of single-agent bortezomib for the treatment of patients with fludarabine-refractory B-cell chronic lymphocytic leukemia [J].

Faderl, Stefan ;

Rai, Kanti ;

Gribben, John ;

Byrd, John C. ;

Flinn, Ian W. ;

O'Brien, Susan ;

Sheng, Shihong ;

Esseltine, Dixie-Lee ;

Keating, Michael J. .

CANCER, 2006, 107 (05) :916-924

[4] Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study [J].

Goy, A. ;

Bernstein, S. H. ;

Kahl, B. S. ;

Djulbegovic, B. ;

Robertson, M. J. ;

de Vos, S. ;

Epner, E. ;

Krishnan, A. ;

Leonard, J. P. ;

Lonial, S. ;

Nasta, S. ;

O'Connor, O. A. ;

Shi, H. ;

Boral, A. L. ;

Fisher, R. I. .

ANNALS OF ONCOLOGY, 2009, 20 (03) :520-525

[5] A phase 2 single-center study of carfilzomib 56 mg/m2 with or without low-dose dexamethasone in relapsed multiple myeloma [J].

Lendvai, Nikoletta ;

Hilden, Patrick ;

Devlin, Sean ;

Landau, Heather ;

Hassoun, Hani ;

Lesokhin, Alexander M. ;

Tsakos, Ioanna ;

Redling, Kaitlyn ;

Koehne, Guenther ;

Chung, David J. ;

Schaffer, Wendy L. ;

Giralt, Sergio A. .

BLOOD, 2014, 124 (06) :899-906

[6] A Phase 1 Dose Escalation Study of the Safety and Pharmacokinetics of the Novel Proteasome Inhibitor Carfilzomib (PR-171) in Patients with Hematologic Malignancies [J].

O'Connor, Owen A. ;

Stewart, A. Keith ;

Vallone, Marcy ;

Molineaux, Christopher J. ;

Kunkel, Lori A. ;

Gerecitano, John F. ;

Orlowski, Robert Z. .

CLINICAL CANCER RESEARCH, 2009, 15 (22) :7085-7091

[7] Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib [J].

Richardson, Paul G. ;

Briemberg, Hannah ;

Jagannath, Sundar ;

Wen, Patrick Y. ;

Barlogie, Bart ;

Berenson, James ;

Singhal, Seema ;

Siegel, David S. ;

Irwin, David ;

Schuster, Michael ;

Srkalovic, Gordan ;

Alexanian, Raymond ;

Rajkumar, S. Vincent ;

Limentani, Steven ;

Alsina, Melissa ;

Orlowski, Robert Z. ;

Najarian, Kevin ;

Esseltine, Dixie ;

Anderson, Kenneth C. ;

Amato, Anthony A. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) :3113-3120

[8] Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma [J].

Robak, Tadeusz ;

Huang, Huiqiang ;

Jin, Jie ;

Zhu, Jun ;

Liu, Ting ;

Samoilova, Olga ;

Pylypenko, Halyna ;

Verhoef, Gregor ;

Siritanaratkul, Noppadol ;

Osmanov, Evgenii ;

Alexeeva, Julia ;

Pereira, Juliana ;

Drach, Johannes ;

Mayer, Jiri ;

Hong, Xiaonan ;

Okamoto, Rumiko ;

Pei, Lixia ;

Rooney, Brendan ;

van de Velde, Helgi ;

Cavalli, Franco .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (10) :944-953

[9] Frontline therapy and role of high-dose consolidation in mantle cell lymphoma [J].

Rule, Simon .

HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2016, :419-424

[10] In Vitro and In Vivo Therapeutic Efficacy of Carfilzomib in Mantle Cell Lymphoma: Targeting the Immunoproteasome [J].

Zhang, Liang ;

Pham, Lan V. ;

Newberry, Kate J. ;

Ou, Zhishuo ;

Liang, Rong ;

Qian, Jianfei ;

Sun, Luhong ;

Blonska, Marzenna ;

You, Yun ;

Yang, Jing ;

Lin, Xin ;

Rollo, Alex ;

Tamayo, Archito T. ;

Lee, John ;

Ford, Richard J. ;

Zhao, Xiurong ;

Kwak, Larry W. ;

Yi, Qing ;

Wang, Michael .

MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11) :2494-2504

← 1 →